Lake Street Maintains Augmedix(AUGX.US) With Buy Rating, Maintains Target Price $3.5

Lake Street analyst Brooks O'Neil maintains $Augmedix(AUGX.US)$ with a buy rating, and maintains the target price at $3.5.According to TipRanks data, the analyst has a success rate of 44.5% and a tota

moomoo NewsJun 4 09:32 ET

Express News | Augmedix Affirms Outlook; Continues To Expect Q2 Revenue To Increase Slightly Sequentially; FY24 Revenue Of $52M - $55M, Est $53.209M

BenzingaJun 4 07:23 ET

Augmedix Expects 2Q Revenue to Increase Slightly From 1Q >AUGX

Augmedix Expects 2Q Revenue to Increase Slightly From 1Q >AUGX

Dow JonesJun 4 07:02 ET

Augmedix Sees 2024 Rev $52M-$55M >AUGX

Augmedix Sees 2024 Rev $52M-$55M >AUGX

Dow JonesJun 4 07:01 ET

Express News | Augmedix Reiterates Second Quarter and Full Year 2024 Outlook

ReutersJun 4 07:00 ET

Augmedix Backs 2024 Guidance>AUGX

Augmedix Backs 2024 Guidance>AUGX

Dow JonesJun 4 07:00 ET